These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 18605517

  • 1. Pharmacologic management of multiple sclerosis.
    Blasier MG.
    Urol Nurs; 2008 Jun; 28(3):217-9. PubMed ID: 18605517
    [No Abstract] [Full Text] [Related]

  • 2. [Pharmacological treatment of multiple sclerosis].
    Myhr KM.
    Tidsskr Nor Laegeforen; 2010 Mar 11; 130(5):490-2. PubMed ID: 20224616
    [Abstract] [Full Text] [Related]

  • 3. A practical approach to immunomodulatory therapy for multiple sclerosis.
    Burks JS.
    Phys Med Rehabil Clin N Am; 2005 May 11; 16(2):449-66, ix. PubMed ID: 15893681
    [Abstract] [Full Text] [Related]

  • 4. The therapy of multiple sclerosis with immune-modulating or immunosuppressive drug. A critical evaluation based upon evidence based parameters and published systematic reviews.
    Clerico M, Rivoiro C, Contessa G, Viglietti D, Durelli L.
    Clin Neurol Neurosurg; 2008 Nov 11; 110(9):878-85. PubMed ID: 18164542
    [Abstract] [Full Text] [Related]

  • 5. 'Time is brain' also in multiple sclerosis.
    Freedman MS.
    Mult Scler; 2009 Oct 11; 15(10):1133-4. PubMed ID: 19808740
    [No Abstract] [Full Text] [Related]

  • 6. [Early immunotherapy in MS reduces the risk of later disability. The secondary progressive course is delayed, according to a study with virtual placebo].
    Tedeholm H, Skoog B, Hillert J, Runmarker B, Stawiarz L, Oluf A.
    Lakartidningen; 2009 Oct 11; 104(22):1684-8. PubMed ID: 17601317
    [No Abstract] [Full Text] [Related]

  • 7. Current disease-modifying therapies in multiple sclerosis.
    Kieseier BC, Hartung HP.
    Semin Neurol; 2003 Jun 11; 23(2):133-46. PubMed ID: 12894379
    [Abstract] [Full Text] [Related]

  • 8. Glatiramer and suspected multiple sclerosis. No proven advantage.
    Prescrire Int; 2010 Aug 11; 19(108):160. PubMed ID: 20941852
    [No Abstract] [Full Text] [Related]

  • 9. Multiple sclerosis: interferon beta for some serious forms.
    Prescrire Int; 2007 Dec 11; 16(92):252-7. PubMed ID: 18092425
    [Abstract] [Full Text] [Related]

  • 10. [Advances in the treatment of multiple sclerosis?].
    Tackenberg B, Himmerich H, Wellek A, Oertel WH, Sommer N.
    MMW Fortschr Med; 2007 May 21; 149 Suppl 2():51-5. PubMed ID: 17724968
    [Abstract] [Full Text] [Related]

  • 11. Disease-modifying drugs for the early treatment of multiple sclerosis.
    Flachenecker P.
    Expert Rev Neurother; 2004 May 21; 4(3):455-63. PubMed ID: 15853542
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of diagnostic tests and procedures for disease-modifying therapy users and non-disease-modifying therapy users with multiple sclerosis.
    Nair KV, Corboy J, Kahler K, Allen RR, Ghushcyan V, McQueen RB, Bainbridge J, Dastani H, Mody-Patel N.
    Expert Rev Neurother; 2011 Jun 21; 11(6):787-98. PubMed ID: 21651327
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Update: treatment of multiple sclerosis].
    Kümpfel T, Hohlfeld R.
    MMW Fortschr Med; 2009 Mar 26; 151(13):70-2. PubMed ID: 19504824
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.